Gender-Related Response to Fluvastatin in Patients with Heterozygous Familial Hypercholesterolaemia

This publication has 10 references indexed in Scilit:

• Efficacy and Tolerability of Lovastatin in 3390 Women with Moderate Hypercholesterolemia
  Annals of Internal Medicine, 1993
• Genetic determinants of responsiveness to the HMG-CoA reductase inhibitor fluvastatin in patients with molecularly defined heterozygous familial hypercholesterolemia.
  1993
• A missense mutation in the low density lipoprotein receptor gene causes familial hypercholesterolemia in Sephardic Jews
  Human Genetics, 1993
• A prospective study of obesity, lipids, apolipoproteins and ischaemic heart disease in women
  Atherosclerosis, 1992
• Haplotype analysis at the low density lipoprotein receptor locus: application to the study of familial hypercholesterolemia in Israel
  Human Genetics, 1992
• Influence of Age and Gender on the Plasma Profiles of 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Inhibitory Activity Following Multiple Doses of Lovastatin and Simvastatin
  Pharmaceutical Research, 1992
• Hypercholesterolemia in five Israeli Christian-Arab kindreds is caused by the ?Lebanese? allele at the low density lipoprotein receptor gene locus and by an additional independent major factor
  Human Genetics, 1991
• Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride.
  Circulation, 1989
• Prognosis after initial myocardial infarction: The Framingham study
  The American Journal of Cardiology, 1979
• Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge
  Clinical Chemistry, 1972